Genetic Technologies (GENE) has released an update.
Genetic Technologies Limited emphasizes a strong commitment to high standards of corporate governance, regularly reviewing and updating policies to align with the ASX Corporate Governance Principles and Recommendations. While adhering to key governance practices, the company pragmatically balances the benefits and costs of implementation, always prioritizing shareholder interests. The governance framework includes a suite of documents ranging from a Code of Conduct to Diversity and Whistle-blower Policies, ensuring the company’s management and strategic direction are in capable hands.
For further insights into GENE stock, check out TipRanks’ Stock Analysis page.
